Skip to main content
. 2020 May 18;20:431. doi: 10.1186/s12885-020-06823-3

Table 1.

Characteristics of study population

Characteristic Patients who completed questionnaires (N = 151) Patients who did not complete any questionnaire (N = 26) Pa
Age, yearsb
 Mean (SD) 63.3 (9.1) 63.7 (8.7) 0.85
 Min, max 37, 83 47, 80
Gender
 Male 82 (54.3) 12 (46.2) 0.53
Ethnicity
 White / Caucasian 142 (94.0) 25 (96.2) 1.00
 Other 9 (6.0) 1 (3.8)
Educationc
 Low 113 (74.8)
 High 32 (21.2)
 Unknown 1 (0.7) 26 (100.0)
Employmentb
 Yes 38 (25.2) 1 (3.8) 0.26
 No 112 (74.2)
 Unknown 1 (0.7) 25 (96.2)
Partner statusb
 Partner 122 (80.8) 1 (3.8) 1.00
 No partner 28 (18.5)
 Unknown 1 (0.7) 25 (96.2)
Cancer stageb
 Locally advanced (IIIB) 19 (12.6) 2 (7.7) 0.76
 Metastatic (IV) 124 (82.1) 23 (88.5)
 Other 8 (5.3) 1 (3.8)
Type of tumorb
 Adenocarcinoma 136 (90.1) 24 (92.3) 1.00
 Large cell carcinoma, mesothelioma, other 15 (9.9) 2 (7.7)
Line of therapy
 irst 140 (92.7) 22 (84.6) 0.24
 econd 11 (7.3) 4 (15.4)
ECOG performance statusb
 Grade 0 or 1 135 (89.4) 18 (69.2) 0.02
 Grade 2 or higher 14 (9.3) 7 (26.9)
 Unknown 2 (1.3) 1 (3.8)

Values are given in numbers (percentages) unless stated otherwise. aP-values reflect differences between patients who completed any questionnaire and those who did not

bMeasured at the start of treatment with chemotherapy

cLow education: persons whose highest level of education is primary education, lower general education or lower vocational education. High education: persons whose highest level of education is higher general education, higher vocational education or university.

Abbreviations: N number of patients, SD standard deviation, ECOG Eastern Cooperative Oncology Group (ECOG)